连续血糖监测对成人1型糖尿病患者生活质量指标的影响:DIAMOND随机临床试验的进一步发现
DIAMOND前瞻性随机试验纳入158例血糖控制不佳的成人1型糖尿病患者,比较连续血糖监测(CGM)与自我血糖监测(SMBG)。24周后CGM组低血糖信心增加更多(P=0.01)、糖尿病痛苦下降更多(P=0.01),而幸福感、健康状况及低血糖恐惧无显著组间差异。
要点
- CGM组较SMBG组低血糖信心增加更多(P=0.01),糖尿病痛苦下降更多(P=0.01)。
- 幸福感、健康状况及低血糖恐惧无显著组间差异。
- CGM满意度与糖尿病痛苦、低血糖恐惧降低及低血糖信心、幸福感增加相关,但与血糖变化无关。
核心结论
- CGM有助于显著改善成人1型糖尿病患者的糖尿病特异性生活质量(即糖尿病痛苦、低血糖信心),但对非糖尿病特异性生活质量指标(即幸福感、健康状况)无显著改善。
研究设计与样本
- DIAMOND为前瞻性随机试验,评估CGM与仅用SMBG在158例血糖控制不佳的成人1型糖尿病患者中的效果,为期24周。
主要发现
- CGM组较SMBG组低血糖信心增加更多(P=0.01),糖尿病痛苦下降更多(P=0.01)。
- 幸福感、健康状况及低血糖恐惧无显著组间差异。
- CGM满意度与血糖变化无显著关联,但与糖尿病痛苦降低(P<0.001)、低血糖恐惧降低(P=0.02)、低血糖信心增加(P<0.001)及幸福感增加(P=0.01)相关。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Continuous glucose monitoring (CGM) improves glycemic control, but data are inconclusive about its influence on quality of life (QOL). We investigated the impact of 24 weeks of CGM use on QOL in adults with type 1 diabetes (T1D) who use multiple daily insulin injections. RESEARCH DESIGN AND METHODS: DIAMOND (Multiple Daily Injections and Continuous Glucose Monitoring in Diabetes) was a prospective randomized trial that assessed CGM versus self-monitoring of blood glucose (SMBG) only in 158 adults with poorly controlled T1D. At baseline and study end, participants completed QOL measures that assessed overall well-being (WHO-5), health status (EQ-5D-5L), diabetes distress (DDS), hypoglycemic fear (worry subscale of the HFS-II), and hypoglycemic confidence (HCS). At study end, CGM participants completed the CGM Satisfaction Survey. Linear regression analyses compared treatment group changes in QOL outcomes over time. Associations between CGM satisfaction and change in QOL outcomes and in glycemic control indices were assessed. RESULTS: The CGM group demonstrated a greater increase in hypoglycemic confidence (P = 0.01) and a greater decrease in diabetes distress (P = 0.01) than the SMBG group. No significant group differences in well-being, health status, or hypoglycemic fear were observed. CGM satisfaction was not significantly associated with glycemic changes but was associated with reductions in diabetes distress (P < 0.001) and hypoglycemic fear (P = 0.02) and increases in hypoglycemic confidence (P < 0.001) and well-being (P = 0.01). CONCLUSIONS: CGM contributes to significant improvement in diabetes-specific QOL (i.e., diabetes distress, hypoglycemic confidence) in adults with T1D, but not with QOL measures not specific to diabetes (i.e., well-being, health status). CGM satisfaction was associated with most of the QOL outcomes but not with glycemic outcomes.
引用
- Polonsky WH, Hessler D, Ruedy KJ, et al. The Impact of Continuous Glucose Monitoring on Markers of Quality of Life in Adults With Type 1 Diabetes: Further Findings From the DIAMOND Randomized Clinical Trial. Diabetes Care. 2017. PMID: 28389582. doi:10.2337/dc17-0133
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。